275.40SEK-1.08%Mkt Cap: —P/E: 1162.031d ago
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…
Industry Peers
Health Information Services$38.07BUSDP/E 44.2
$40.77BUSDP/E 44.6
$11.74BUSDP/E 53.0
$11.05BUSD
$8.71BUSDP/E 38.9
$8.10BUSD
$7.14BUSDP/E 10.8
$4.76BUSDP/E 35.5
$4.62BUSDP/E 30.9
$3.96BUSD
$2.75BUSDP/E 97.7
$1.66BUSDP/E 43.4
$1.50BUSDP/E 36.5
$1.48BUSD
$1.28BUSD
$1.21BUSDP/E 59.0
$1.18BUSD
$870.57MUSD
$834.80MUSDP/E 39.7
$738.82MUSDP/E 74.8
Key Statistics
Company
Market Cap—
Enterprise Value830.32M $
Revenue (TTM)85.63M $
Gross Profit61.89M $
Net Income (TTM)8.47M $
Revenue/Share2.718 USD
Last Price275.40 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees197
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISINSE0004840718
Valuation
P/E (Trailing)1162.03
P/E (Forward)—
PEG—
EV/EBITDA54.85
EV/Revenue9.70
P/S—
P/B4.03
EPS (TTM)0.24
EPS (Forward)—
52W Range
272.3029% of range283.00
52W High283.00 SEK
52W Low272.30 SEK
Profitability
Gross Margin72.27%
Oper. Margin10.46%
EBITDA Margin17.68%
Profit Margin9.89%
ROE4.13%
ROA2.99%
Growth
Revenue Growth34.00%
Earnings Growth935.10%
Cash Flow & Leverage
Operating CF22.61M $
CapEx (TTM)—
FCF Margin-3.24%
FCF Yield—
Net Debt-17.54M $
Net Debt/EBITDA-1.16
Balance Sheet
Debt/Equity5.53
Current Ratio3.86
Quick Ratio2.65
Book Value/Sh69.85 SEK
Cash/Share9.682 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.26.40M
Float25.13M
Insiders8.33%
Institutions59.25%
Technical
SMA 50291.55 (-5.5%)
SMA 200282.98 (-2.7%)
Beta1.46
S&P 52W Chg20.80%
Avg Vol (30d)2.34K
Avg Vol (10d)4.45K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—